JENKINS GEORGE M sold 17.2% of their position (27.50K shares) of PALVELLA THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.58M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−5.09K
Price / share
$132.62
Trade value
$675.68K
% of position
Common Stock
Shares
−2.46K
Price / share
$133.25
Trade value
$327.52K
% of position
Common Stock
Shares
−3.33K
Price / share
$134.21
Trade value
$447.59K
% of position
Common Stock
Shares
−1.45K
Price / share
$135.50
Trade value
$196.06K
% of position
Common Stock
Shares
−817.00
Price / share
$136.44
Trade value
$111.48K
% of position
Common Stock
Shares
−2K
Price / share
$128.52
Trade value
$257.56K
% of position
Common Stock
Shares
−1.64K
Price / share
$129.23
Trade value
$212.45K
% of position
Common Stock
Shares
−990.00
Price / share
$130.48
Trade value
$129.18K
% of position
Common Stock
Shares
−1.03K
Price / share
$131.49
Trade value
$136.09K
% of position
Common Stock
Shares
−579.00
Price / share
$132.40
Trade value
$76.66K
% of position
Common Stock
Shares
−922.00
Price / share
$133.72
Trade value
$123.29K
% of position
Common Stock
Shares
−476.00
Price / share
$121.14
Trade value
$57.66K
% of position
Common Stock
Shares
−2.07K
Price / share
$122.62
Trade value
$254.06K
% of position
Common Stock
Shares
−2.60K
Price / share
$123.29
Trade value
$321.05K
% of position
Common Stock
Shares
−920.00
Price / share
$124.37
Trade value
$114.42K
% of position
Common Stock
Shares
−597.00
Price / share
$125.33
Trade value
$74.82K
% of position
Common Stock
Shares
−505.00
Price / share
$126.55
Trade value
$63.91K
% of position
Net shares
−27.50K
Net value
-$3.58M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/12/2026 | S · Sale | −5.09K | $132.62 | $675.68K | 3.2% | 160.12K | 155.02K |
| Common Stock Direct | 10/12/2026 | S · Sale | −2.46K | $133.25 | $327.52K | 1.6% | 155.02K | 152.56K |
| Common Stock Direct | 10/12/2026 | S · Sale | −3.33K | $134.21 | $447.59K | 2.2% | 152.56K | 149.23K |
| Common Stock Direct | 10/12/2026 | S · Sale | −1.45K | $135.50 | $196.06K | 1.0% | 149.23K | 147.78K |
| Common Stock Direct | 10/12/2026 | S · Sale | −817.00 | $136.44 | $111.48K | 0.6% | 147.78K | 146.96K |
| Common Stock Direct | 10/13/2026 | S · Sale | −2K | $128.52 | $257.56K | 1.4% | 146.96K | 144.96K |
| Common Stock Direct | 10/13/2026 | S · Sale | −1.64K | $129.23 | $212.45K | 1.1% | 144.96K | 143.32K |
| Common Stock Direct | 10/13/2026 | S · Sale | −990.00 | $130.48 | $129.18K | 0.7% | 143.32K | 142.33K |
| Common Stock Direct | 10/13/2026 | S · Sale | −1.03K | $131.49 | $136.09K | 0.7% | 142.33K | 141.29K |
| Common Stock Direct | 10/13/2026 | S · Sale | −579.00 | $132.40 | $76.66K | 0.4% | 141.29K | 140.71K |
| Common Stock Direct | 10/13/2026 | S · Sale | −922.00 | $133.72 | $123.29K | 0.7% | 140.71K | 139.79K |
| Common Stock Direct | 10/14/2026 | S · Sale | −476.00 | $121.14 | $57.66K | 0.3% | 139.79K | 139.31K |
| Common Stock Direct | 10/14/2026 | S · Sale | −2.07K | $122.62 | $254.06K | 1.5% | 139.31K | 137.24K |
| Common Stock Direct | 10/14/2026 | S · Sale | −2.60K | $123.29 | $321.05K | 1.9% | 137.24K | 134.64K |
| Common Stock Direct | 10/14/2026 | S · Sale | −920.00 | $124.37 | $114.42K | 0.7% | 134.64K | 133.72K |
| Common Stock Direct | 10/14/2026 | S · Sale | −597.00 | $125.33 | $74.82K | 0.4% | 133.72K | 133.12K |
| Common Stock Direct | 10/14/2026 | S · Sale | −505.00 | $126.55 | $63.91K | 0.4% | 133.12K | 132.62K |
| Total | −27.50K | -$3.58M | ||||||
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.52K | Indirect |
| Total | 13.52K | 13.52K indirect |